These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 217716)
1. Effects of [N-(2-oxo-3,5,7-cycloheptatrien-1-yl)] aminooxoacetic acid ethyl ester (AY-25,674) on cyclic 3',5'-nucleotide formation and phosphodiesterase activity. Pugsley TA; Lippmann W Experientia; 1979 Jan; 35(1):88-90. PubMed ID: 217716 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of passive anaphylaxis induced in the rat hind paw and peritoneal cavity by N-(2-oxo-3,5,7-cycloheptatrien-1-yl)-aminooxoacetic acid ethyl ester (AY-25,674). Martel PR; Klicius J; Pinski J Can J Physiol Pharmacol; 1978 Dec; 56(6):1005-10. PubMed ID: 743615 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds. Tateson JE; Trist DG Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695 [No Abstract] [Full Text] [Related]
4. Interactions of chlorphenesin and divalent metal ions with phosphodiesterase. Edelson J; McMullen JP Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):24-33. PubMed ID: 187130 [TBL] [Abstract][Full Text] [Related]
5. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385 [TBL] [Abstract][Full Text] [Related]
6. Troponoids. 3. Synthesis and antiallergy activity of N-troponyloxamic acid esters. Bagli JF; Bogri T; Palameta B; Martel R; Robinson W; Pugsley T; Lippmann W J Med Chem; 1979 Oct; 22(10):1186-93. PubMed ID: 229222 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of 3', 5'-cyclic AMP phosphodiesterase in the guinea pig lung by a new anti-allergic: 10-(3-quinuclidinylmethyl) phenothiazine (LM 209)]. Uzan A; Le Fur G Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):160-8. PubMed ID: 178283 [TBL] [Abstract][Full Text] [Related]
8. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism. Ahn HS; Eardley D; Watkins R; Prioli N Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728 [TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase inhibition in ventricular cardiomyocytes from guinea-pig hearts. Bethke T; Meyer W; Schmitz W; Scholz H; Stein B; Thomas K; Wenzlaff H Br J Pharmacol; 1992 Sep; 107(1):127-33. PubMed ID: 1384905 [TBL] [Abstract][Full Text] [Related]
10. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside. Turner NC; Lamb J; Worby A; Murray KJ Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589 [TBL] [Abstract][Full Text] [Related]
11. The effect of triamterene on myocardial phosphodiesterase and adenylate cyclase. Schuhmacher P; Greeff K; Noack EA Eur J Pharmacol; 1983 Nov; 95(1-2):71-7. PubMed ID: 6321204 [TBL] [Abstract][Full Text] [Related]
12. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone. Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594 [TBL] [Abstract][Full Text] [Related]
13. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo. Raeburn D; Karlsson JA J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium. Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013 [TBL] [Abstract][Full Text] [Related]
16. New substituted triaza-benzo[cd]azulen-9-ones as promising phosphodiesterase-4 inhibitors. Devillers I; Pevet I; Jacobelli H; Durand C; Fasquelle V; Puaud J; Gaudillière B; Idrissi M; Moreau F; Wrigglesworth R Bioorg Med Chem Lett; 2004 Jun; 14(12):3303-6. PubMed ID: 15149695 [No Abstract] [Full Text] [Related]
17. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982 [TBL] [Abstract][Full Text] [Related]
18. Requirement of additional adenylate cyclase activation for the inhibition of human eosinophil degranulation by phosphodiesterase IV inhibitors. Ezeamuzie CI Eur J Pharmacol; 2001 Apr; 417(1-2):11-8. PubMed ID: 11301054 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases. Helfman DM; Kuo JF Biochem Pharmacol; 1982 Jan; 31(1):43-7. PubMed ID: 6277336 [TBL] [Abstract][Full Text] [Related]
20. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors. Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]